News | Heart Failure | November 21, 2022

Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology

Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association.

November 21, 2022 — Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association. With risk factors for cardiovascular disease such as obesity and type 2 diabetes on the rise in the US, the field of cardiovascular medicine finds itself in need of a paradigm shift to improve the cardiovascular health of our nation. 

In a concerted effort to move the needle, clinicians specializing in the prevention of cardiovascular disease, along with the American Society for Preventive Cardiology (ASPC), are rapidly growing the subspecialty referred to commonly as "preventive cardiology". 

 "The importance of cardiovascular disease prevention has never been more urgent for the United States and the world." shares President of the ASPC, Dr. Martha Gulati. "Changing our focus from 'sick care' to true 'health care' starts with cardiovascular disease prevention, and this will be led by preventive cardiologists. This important statement from ASPC should serve as a guide to our cardiology community towards an approach to improve the heart health of our patients." 

Recently published in the American Journal of Preventive Cardiology, this clinical practice statement endorsed by the ASPC delineates the key attributes that define the field of preventive cardiology. Lead author, Charles German, MD shares the importance of this publication: "Despite concerted efforts, high rates of cardiovascular diseases continue to plague our society. Preventive cardiologists are needed now more than ever to help improve the cardiovascular health of our population, and we hope this statement helps bring clarity and unity to the field." 

For more information: https://www.sciencedirect.com/science/article/pii/S2666667722001167  


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now